Sveriges mest populära poddar
Hematologic Oncology Update
Hälsa och motionMedicin

Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review

19 min•9 mars 2026

Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.

CME information and select publications here.

Fler avsnitt av Hematologic Oncology Update

Visa alla avsnitt av Hematologic Oncology Update
Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review
•25 min
CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson
•24 min
Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review
•29 min
CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah
•1 tim 3 min
Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
•47 min
Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review
•24 min
Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
•58 min
Relapsed/Refractory Multiple Myeloma — Microlearning Activity 2 with Dr Sagar Lonial: ASH 2025 Review
•17 min
Immune Thrombocytopenia — ASH 2025 Review
•1 tim 30 min
Relapsed/Refractory Multiple Myeloma — Microlearning Activity 1 with Dr Sagar Lonial: ASH 2025 Review
•23 min

Hematologic Oncology Update med Dr. Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.